Virtu Financial LLC Veracyte, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Sep 17, 2021	SELL	$32.94 - $56.62 $412,145 - $708,429	-12,512 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$44.47 - $81.38 $341,262 - $624,510	7,674 Added 158.62%	12,512 $673,000
Q4 2020 Feb 24, 2021	BUY	$32.49 - $61.88 $157,186 - $299,375	4,838 New	4,838 $237,000
Q4 2018 Jan 16, 2019	SELL	$9.15 - $14.85 $475,013 - $770,922	-51,914 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$9.55 - $12.64 $495,778 - $656,192	51,914 New	51,914 $496,000

308

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.83B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.